Why the study?
Does epidural fentanyl cause adverse maternal and fetal cardiovascular effects in a sheep model?
Does epidural fentanyl cause adverse maternal and fetal cardiovascular effects in a sheep model?
Epidural fentanyl at 50 and 100 μg doses does not cause adverse maternal or fetal cardiovascular effects in a sheep model.
Does not support changes in human obstetric practice; extends preclinical safety data in sheep models.
Since the demonstration of opiate receptors in the spinal cord in the mid-1970s, investigators have been looking for the most effective epidural narcotic. With the use of the chronically catheterized maternal sheep model, we injected two different doses of preservative-free fentanyl (50 and 100 μg) into the epidural space. No statistically significant changes were observed, either in maternal or fetal arterial pressure and acid-base status or in maternal central venous pressure, systemic and pulmonary vascular resistance, cardiac output, and intrauterine pressure (p > 0.05). With a dose of 50 μg of fentanyl, maternal levels of fentanyl peaked at 60 minutes (50 pg/ml) and the fetal levels of fentanyl peaked at 45 minutes (20 pg/ml). With the 100 μg dose of fentanyl, maternal levels of fentanyl peaked at 45 minutes (230 pg/ml) and the fetal levels peaked at 15 minutes (110 pg/ml). We conclude that the injection of 50 and 100 μg of fentanyl into the maternal epidural space has no adverse effects on mother or fetus in the sheep model.
No takes yet. Share an insight, caveat, or question.
Craft et al. (1984) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: